RT Journal Article
SR Electronic
T1 Frequency of routine testing for COVID-19 in high-risk healthcare environments to reduce outbreaks
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.30.20087015
DO 10.1101/2020.04.30.20087015
A1 Chin, Elizabeth T
A1 Huynh, Benjamin Q
A1 Chapman, Lloyd A. C.
A1 Murrill, Matthew
A1 Basu, Sanjay
A1 Lo, Nathan C
YR 2020
UL http://medrxiv.org/content/early/2020/09/09/2020.04.30.20087015.abstract
AB AbstractRoutine asymptomatic testing strategies for COVID-19 have been proposed to prevent outbreaks in high-risk healthcare environments. We used simulation modeling to evaluate the optimal frequency of viral testing. We found that routine testing substantially reduces risk of outbreaks, but may need to be as frequent as twice weekly.Competing Interest StatementThe authors have declared no competing interest.Funding StatementE.T.C acknowledges support by the National Science Foundation Graduate Research Fellowship under Grant No. DGE 1656518. NCL and LACC are supported by the University of California, San Francisco. B.Q.H acknowledges support by the National Science Foundation Graduate Research Fellowship under Grant No. DGE 1656518 and the National Library of Medicine under Training Grant T15 LM 007033. Funding sources had no role in the writing of this correspondence or the decision to submit for publication. Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData and code available at: https://github.com/etchin/covid-testing.